Benzinga | Aug 16, 2021 08:24AM EDT

NeuroBo Pharmaceuticals Q2 EPS $(0.18) Down From $(0.15) YoY

NeuroBo Pharmaceuticals (NASDAQ:NRBO) reported quarterly losses of $(0.18) per share. This is a 20 percent decrease over losses of $(0.15) per share from the same period last year.